Adjuvant Systemic Therapy Improved Survival after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
ANNALS OF SURGICAL ONCOLOGY(2024)
Abstract
The purpose of this study was to test for survival differences according to adjuvant chemotherapy (AC) status in radical nephroureterectomy (RNU) patients with pT2–T4 and/or N1–2 upper tract urothelial carcinoma (UTUC). Within the Surveillance, Epidemiology, and End Results database (SEER, 2007–2020), patients with UTUC treated with AC versus RNU alone were identified. Kaplan–Meier plots and multivariable Cox regression models addressed cancer-specific mortality (CSM). Of 1995 patients with UTUC, 804 (40
MoreTranslated text
Key words
Systemic therapy,UTUC,SEER,Disease-free survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined